These CAR‐T cells also controlled the growth of murine glioblastoma tumors without overt toxicity, even in the face of heterogeneous target antigen expression, suggesting FAP‐CAR‐T cells as a promising new approach for the treatment of glioblastoma. This evidence concerns the gene FAP and glioblastoma.